INTRODUCTION
The ability of networks to maintain stable function over time, and to efficiently store information, is thought to rely on homeostatic plasticity mechanisms that stabilize neuronal and network activity (Davis, 2013; Turrigiano and Nelson, 2004) . Synaptic scaling is a form of homeostatic plasticity that scales postsynaptic strength up or down in response to perturbations in neuronal firing (Gainey et al., 2009 (Gainey et al., , 2015 Goold and Nicoll, 2010; Ibata et al., 2008) , a process thought to contribute to the stabilization of firing rates both in vitro and in vivo (Hengen et al., 2013 (Hengen et al., , 2016 . Synaptic scaling is accomplished through changes in the abundance of postsynaptic AMPA receptors (AMPARs), but despite great effort, the full set of molecular trafficking events that homeostatically adjust synaptic AMPAR abundance is poorly understood (Pozo and Goda, 2010; Turrigiano, 2012) . In particular, although synaptic scaling is known to be transcription dependent (Gainey et al., 2015; Goold and Nicoll, 2010; Ibata et al., 2008; Meadows et al., 2015) , the factor or factors that are transcriptionally regulated to drive synaptic scaling are largely unknown. We thus set out to devise an unbiased screen for factors that are persistently upregulated during synaptic scaling in the hopes of gaining deeper insight into the transcription-dependent AMPAR trafficking pathways involved in this critical form of synaptic plasticity.
Synaptic scaling up is induced within primary visual cortex (V1) by brief sensory deprivation (Desai et al., 2002; Lambo and Turrigiano, 2013) . Several studies have examined the transcriptional changes within extracts of V1 following visual deprivation protocols (Lachance and Chaudhuri, 2004; Majdan and Shatz, 2006; Tropea et al., 2006) . However, these earlier studies probed tissue derived from total V1, including all cell types and all layers. This is problematic, because synaptic scaling is expressed in a cell-type-and layer-specific manner (Desai et al., 2002; Maffei and Turrigiano, 2008) ; therefore, this approach does not provide the necessary sensitivity to isolate transcripts that are specifically involved in synaptic scaling. For this reason, we designed a screen that would allow us to probe for transcriptional changes in a defined population of pyramidal neurons in which we know synaptic scaling is induced. Two days of visual deprivation via intraocular tetrodotoxin (TTX) injection induces synaptic scaling up of miniature excitatory postsynaptic currents (mEPSCs) onto layer 4 (L4) star pyramidal neurons in rodent visual cortex during early postnatal development (Desai et al., 2002) . Here we generated a mouse with mCitrine expressed within these L4 star pyramids, allowing us to probe for transcriptional changes in this specific cell population (Sugino et al., 2006) . This highly targeted approach revealed a relatively small number of transcripts (30) with expression changes that reached the criterion (fold change > 1.5, p < 0.0034) following visual deprivation.
Surprisingly, two of these, Ap3m1 and Ap4m, code for m subunits (m3A and m4, respectively) of the heterotetrameric clathrin adaptor protein (APC) complexes AP-3 and AP-4. The APC family is composed of five members (AP-1 through AP-5) that sort and shuttle membrane-bound cargo between different endosomal and cell-surface compartments (Faú ndez et al., 1998; Hirst et al., 2013; Le Borgne et al., 1998; Nakatsu and Ohno, 2003; Newell-Litwa et al., 2007; Robinson and Bonifacino, 2001; Simpson et al., 1997) ; the m subunits are critical for most cargo recognition (Bonifacino and Traub, 2003; Mardones et al., 2013; Ohno et al., 1998; Traub and Bonifacino, 2013) . Although none of these complexes were previously known to have activity-regulated expression, several of them have been implicated in basal sorting and trafficking of glutamate receptors (Margeta et al., 2009; Kastning et al., 2007; Lee et al., 2002) . In particular, m3A and m4 can bind AMPAR indirectly through interactions with transmembrane AMPR regulatory proteins (TARPs) (Matsuda et al., 2008 (Matsuda et al., , 2013 , and this interaction is important for dendritic trafficking of AMPAR (Matsuda et al., 2008) and for N-methyl-D-aspartate (NMDA)-induced trafficking of internalized AMPAR from early endosomes (EEs) to lysosomes (AP-3; Matsuda et al., 2013) . These considerations suggest that m3A could contribute to the regulated trafficking of AMPAR that underlies synaptic scaling up (Kennedy and Ehlers, 2006; Turrigiano, 2008 ).
Here we show that m3A upregulation plays an essential role in synaptic scaling up by trafficking GluA2-containing AMPAR into the recycling pathway. AP-3 is classically known for sorting membrane proteins into the lysosomal pathway for degradation (Bonifacino and Traub, 2003) , so it was surprising to find that TTX treatment rerouted m3A from lysosomes to recycling endosomes (REs). Both TTX treatment and overexpression (OE) of m3A were able to drive AMPAR into the RE pathway, as was OE of a truncated m3A that cannot interact with the rest of the AP-3 complex (Mardones et al., 2013) . Furthermore, knockdown (KD) of m3A, which blocks the normal increase in m3A induced by activity blockade, prevented the activity-dependent rerouting AMPAR to REs and blocked synaptic scaling. Finally, OE of m3A acted synergistically with the GluA2 trafficking protein GRIP1 to recruit AMPAR to the dendritic surface. Taken together, these data show that activity blockade transcriptionally upregulates m3A to reroute AMPAR into the RE pathway and is essential for the recruitment of AMPAR to the cell surface during synaptic scaling up ( Figure S1 ).
RESULTS
We set out to identify in an unbiased manner a set of candidate ''scaling factors'' that might participate in transcription-dependent synaptic scaling up. The ex vivo slice and profiling studies were conducted on HsCt5 mice (described later) at postnatal day (P) 14 to P15, an age at which synaptic scaling can be induced within L4 star pyramidal neurons by 2 days of optic nerve blockade using intraocular TTX ( Figure 1A ; Desai et al., 2002) . In vitro experiments were performed on postnatal visual cortical cultures after 7-8 days in vitro, and pyramidal neurons were targeted using standard morphological features as described (Watt et al., 2000) .
Generation and Characterization of the HsCt5 Mouse
The HsCt5 mouse was generated as part of a lentiviral enhancer trap screen (Kelsch et al., 2012; Shima et al., 2016) through random insertion of a lentiviral vector containing the tet-transactivator (tTA) driving mCitrine. Upon screening lines for restricted mCitrine expression, the HsCt5 line was identified as having expression largely restricted to neocortical L4 (Figure 1B; Figure S2A) . For many labeled neurons in V1, a thin apical dendrite could be discerned ( Figure S2B ), as is typical of star pyramidal neurons (Desai et al., 2002; Maffei et al., 2004) . When slices were fixed and stained against g-aminobutyric acid (GABA; Figures S2B and S2C) 97.5% of mCitrine + neurons were GABA negative (n = 685 cells from three animals). Whole-cell current clamp recordings from labeled neurons in slices from V1 revealed that recorded neurons had regular-spiking properties, and fills revealed the typical star-pyramid morphology ( Figure 1C , n = 5). Thus, most labeled neurons were excitatory star pyramidal neurons. Next, we verified that excitatory synapses onto labeled neurons undergo synaptic scaling up upon visual deprivation. We used an established protocol (Desai et al., 2002; Maffei and Turrigiano, 2008) to block optic nerve impulses with intraocular TTX injections for 2 days commencing just before eye opening (P12; Figure 1A ). Only one optic nerve was blocked, allowing us to use the contralateral monocular V1 from the same animals as a control. Slice recordings were then obtained from mCitrine + neurons in either the deprived or the control hemisphere, and AMPAR-mediated mEPSCs measured as described previously ( Figure 1D ; Desai et al., 2002; Maffei and Turrigiano, 2008) . Consistent with our previous findings in rats (Desai et al., 2002) , 2 days of optic nerve block significantly increased mEPSC amplitude in mCitrine + neurons ( Figures 1E and 1F , n = 11 each condition, p = 0.015) without affecting mEPSC frequency (p = 0.17), mEPSC kinetics (rise and decay times, p > 0.29; Figure 1F , peak-scaled mEPSC waveforms), or passive cellular properties (R in , input resistance; V m , resting membrane potential; membrane capacitance, C m ; p > 0.05). Furthermore, mEPSC amplitude was scaled up multiplicatively ( Figure 1E ), as is characteristic of synaptic scaling both in vitro and in vivo at this developmental stage (Desai et al., 2002; Goel and Lee, 2007) .
Microarray Screen for the Synaptic-Scaling-Associated Transcriptome To probe for candidate synaptic scaling factors with expression levels persistently and significantly altered by visual deprivation, we used the same deprivation paradigm described earlier (Figure 1A) and then isolated the monocular portion of V1 from both the deprived and the control hemispheres. L4 mCitrine + cells were isolated and manually sorted, and their mRNA was linearly amplified and used to probe affymetrix microarrays as previously described (see Experimental Procedures; Sugino et al., 2006) . Expression levels were then compared between the control and the deprived hemisphere in three biological replicates. We identified the top 30 differentially expressed transcripts based on robust expression changes (fold change > 1.5), rankordered by p value (Table 1) . None of the classic activity-regulated genes (such as c-Fos, Arc, BDNF, or Npas1-4; Flavell and Greenberg, 2008) , some of which (BDNF and Arc) have previously been implicated in synaptic scaling (Shepherd et al., 2006; Rial Verde et al., 2006; Rutherford et al., 1998) , showed changes in expression that reached the criterion, likely because the manipulation we used here (2 days of optic nerve block) is subtle relative to classic activity deprivation or enhancement paradigms, such as prolonged enucleation and dark rearing or high K+ and seizure induction (Flavell and Greenberg, 2008; Nedivi et al., 1993) . There was also no change in expression of AMPAR or other glutamate receptor subunits. Finally, transcripts coding for a number of trafficking proteins, regulatory proteins, and kinases previously implicated in synaptic scaling (including GRIP1, PICK1, Homer1, PSD-95, Narp1, Plk2, CDK5, DHHC2, CaMKIV, and MeCP2; Tur- rigiano, 2012), did not reach the criterion for altered expression (Table S1 ). None of the top differentially expressed transcripts have previously been implicated in synaptic scaling. These include Ptprj (a protein tyrosine phosphatase), Map3k2 (a member of the mitogen-activated protein [MAP] kinase pathway), and Dbp (the clock gene D site albumin promoter binding protein; Table 1 ). There were several transcripts involved in ubiquitin processing, including Ube2g1 (a ubiquitin-conjugating enzyme), Usp48 (a predicted but uncharacterized ubiquitin peptidase), and Anapc1 (anaphase promoting complex 1, a member of a large E3 ubiquitin ligase complex), and several with known or putative involvement in protein trafficking, including Dync2h1 (cytoplasmic dynein 2 heavy chain 1), Dlg1 (the trafficking/scaffold protein SAP97), and Ap3m1 and Ap4m (m subunits of the tetrameric clathrin adaptor protein complex, or APC, family members AP-3 and AP-4). The two most significant hits in this group were Ap3m1 (coding for m3A) and Ap4m (coding for m4), which increased 2.9-and 2.2-fold, respectively (Table 1) . None of the other AP-3 or AP-4 subunits showed altered expression, and a second isoform of Ap3m, Ap3m2 (coding for m3B), was unaffected.
To determine whether these expression changes were predictive of increased protein levels during synaptic scaling, we analyzed a subset of these hits using quantitative immunohistochemistry in vitro (Figure 2 ; Figure S6A ). We treated neocortical cultures with TTX for 6 hr (a period sufficient to induce transcription-dependent scaling up in vitro; Ibata et al., 2008; Gainey et al., 2015) ; fixed, permeabilized, and stained against SAP97, m3, or profilin 1; and then quantified the intensity of the signal within the somatic and dendritic compartments of morphologically identified pyramidal neurons as described (Figure 2 ; see also Experimental Procedures; Gainey et al., 2015) . Because there were no reliable commercially available antibodies against m3 that worked for immunohistochemistry, we generated and characterized a m3 rabbit polyclonal antibody (see also Experimental Procedures; Figure S3 ). There is 80% homology between m3A and m3B (Pevsner et al., 1994) , so this antibody recognizes both m3 subunits but does not recognize other m subunits, such as m4 ( Figure S3B ). SAP97 ( Figures 2A-2C , n = 10-24 neurons/condition) and m3 ( Figures 2D and 2E , n = 16-23 neurons/condition) increased in a transcription-dependent manner within pyramidal neuronal dendrites (Figures 2B and 2E) and somata ( Figure 2C ) following TTX treatment. Another means of inducing synaptic scaling up is to express a dominant-negative form of CaMKIV in pyramidal neurons (Ibata et al., 2008; Pratt et al., 2011) . Like TTX treatment, this significantly increased m3 protein in pyramidal neuron dendrites ( Figure 2F , n = 11-13 neurons/condition, p < 0.04). In contrast, the profilin 1 signal was not significantly elevated by 6 hr TTX treatment (p > 0.07); thus, two of the three hits tested showed rapid upregulation at the protein level during synaptic scaling.
AP-3A is a heterotetrameric complex. To determine whether other subunits increased in tandem with m3, we double-labeled against m3 and the d subunit d3, which is obligatory for full AP-3 complex formation (Kantheti et al., 1998; Peden et al., 2002) . Both antibodies recognized endosomal compartments within the soma and dendrites, and 50% of d3 dendritic puncta had detectible levels of colocalized m3 ( Figure 2G ). Although TTX increased both total m3 ( Figure 2H ) and m3 at colocalized sites ( Figure 2I , p < 0.05), neither total d3 nor colocalized d3 were elevated by TTX ( Figures 2H and 2I , n = 17-20 neurons/condition). Thus, consistent with our microarray data, synaptic scaling is associated with a selective increase in the m3 protein with no change in d3. Furthermore, a significant fraction of endosomal compartments contains detectible m3 without detectible d3 ( Figure 2G ).
Synaptic Scaling Changes the Endosomal Distribution of m3 AP-3A, which associates indirectly with AMPAR through m3A binding to TARPs, has been implicated in the sorting and trafficking of glutamate receptors (Matsuda et al., 2013) , suggesting that transcriptional upregulation of m3A might play a critical role in synaptic scaling. As expected, immunohistochemistry localized m3 to a number of endosomal compartments within pyramidal neurons ( Figures 3A-3F ), including a subset of those labeled with internalized transferrin receptor (TfR, a marker of RE), EEA1 (a marker of EEs), and LAMP1 (a lysosomal marker).
To determine whether TTX increases the accumulation of m3 within specific endosomal compartments, we performed double-labeling against m3 and LAMP1 (lysosomes), TfR (RE), (H and I) Quantification of puncta intensity for all m3 and d3 dendritic puncta (H) and for colocalized puncta (I) following TTX treatment. *p < 0.05 indicates different from control; **p < 0.01; sample sizes are given in the text. All summary data are expressed as mean ± SEM. See also Figure S3 for m3 antibody characterization.
or EEA1 (EE) and quantified the intensity of the m3 signal at colocalized sites. The m3 signal associated with RE and EE was unchanged in the cell body but was significantly elevated in the dendrites ( Figures 3G and 3H , n = 9-11 neurons/ condition, p = 0.007 RE, p = 0.017 EE). In contrast, the m3 signal associated with the lysosomal compartment decreased following TTX treatment in the cell body ( Figure 3I , n = 9-14 neurons/condition, p < 0.01). Thus, TTX reduces the association of m3 with lysosomes while increasing its association with dendritic RE and EE. TTX did not significantly affect the colocalization rates between m3 and these various endosomal markers (data not shown). As a control, we verified that the experimental colocalization rate between m3 and TfR is significantly higher than expected if the distribution of m3 were random relative to the TfR signal, as described (Gainey et al., 2015) ; we ran the same control for triple colocalization among GluA2, m3, and TfR and found that the observed rates were many fold higher than predicted for random association ( Figure S4 ).
Upregulation of m3A Is Necessary for Synaptic Scaling
To determine whether m3A is necessary for synaptic scaling up, we designed two small hairpin RNAs (shRNAs) targeted against two distinct and unique regions of the m3A mRNA to knock down expression of m3A, an approach that allowed us to target m3A in an acute and cell-autonomous manner, thus avoiding circuit level and developmental defects due to prolonged loss of m3A. Neurons were transfected with the hairpins or an empty vector (EV), along with EGFP at low efficiency (Figure S6 ) for 3 days, and then fixed, stained, and processed for immunohistochemistry against m3. Both shRNAs reduced the intensity of m3 staining in the somatic and dendritic compartments to 60% and 40% of control, respectively ( Figures  4A and 4B , n = 9-13 neurons/condition, p < 0.05 for soma, p < 0.01 for dendrite). This likely represents an underestimate of the degree of m3A KD, because the shRNAs are specific for m3A but the antibody recognizes both m3A and m3B (Figure S3B) . Importantly, in KD neurons, TTX treatment was not able to increase m3 expression in either the cell body or the dendrites ( Figure 4C ).
Pyramidal neurons transfected with the EV showed normal synaptic scaling up of mEPSC amplitude following 6 hr TTX ( Figures 4D and 4E , n = 12-16 neurons/condition, p = 0.01). In contrast, neurons in which m3A had been knocked down using either shRNA, which target unique and distinct sequences in the m3A mRNA, failed to show synaptic scaling up ( Figures 4D  and 4E , n = 9-11 neurons/condition). Neither shRNA affected baseline mEPSC amplitude ( Figure 4E , ANOVA, p = 0.61) or frequency (ANOVA, p = 0.79). Synaptic scaling in neocortical pyramidal neurons operates primarily through changes in synaptic accumulation of AMPAR (Turrigiano, 2008) , so we next examined the ability of m3A KD to prevent the TTX-induced enhancement of surface AMPAR. The intensity of the surface punctate GluA2 signal was increased by TTX treatment as expected ( Figures  4F and 4G , n = 9-12 neurons/condition, p = 0.04), and this increase was completely blocked by m3A KD (Figure 4G, shm3A#1) ; similar results were obtained with GluA1 (data not shown). Finally, coexpression of an RNAi-insentitive m3A (m3AshR) was able to rescue the effects of endogenous m3A KD (4G, shm3A#1 + m3AshR); together with our earlier data using two distinct hairpins, this shows that the inability of neurons to undergo synaptic scaling is not the result of off-target effects of the shRNA.
m3A Is Necessary to Traffic GluA2 to RE during Synaptic Scaling Up
The preceding data suggest that enhanced expression of m3A is critical for the regulated delivery of AMPARs to synapses during synaptic scaling. AMPARs are thought to be mobilized to the dendritic surface from RE and/or EE (Park et al., 2004) , and we found that dendritic m3A increases in both RE and EE during synaptic scaling ( Figures 3G and 3H) . We thus wondered whether m3A might play an important role in trafficking AMPAR to these compartments during scaling. To test this, we first asked whether m3A and GluA2 are colocalized within RE and whether the amount of GluA2 at such colocalized sites is affected by TTX treatment. RE were labeled with TfR, and internal GluA2 was labeled by applying antibody to the surface, waiting 45 min for receptor internalization, stripping surface antibody, and then permeabilizing and staining for m3 ( Figure 5A ; Tatavarty et al., 2013; Gainey et al., 2015) . A significant fraction of internalized GluA2 puncta were colocalized with m3 in RE ( Figure 5B , left panel, 18% in dendritic compartments), many fold higher than expected for random colocalization ( Figure S4 ). Although TTX did not affect the fraction of RE with detectible GluA2 and m3, there was a significant increase in the intensity of both the GluA2 and the m3 signal within this population of dendritic RE following TTX treatment ( Figures 5C and 5D , n = 12-13 neurons/condition). Thus, TTX treatment simultaneously enhances the accumulation of GluA2 and m3 within a subset of dendritic RE.
Next, we asked whether this TTX-induced enhancement of GluA2 in RE depends on m3A. Neurons were transfected with either EV or shm3A, and internal GluA2 in RE was labeled as earlier ( Figure 6A ). In the EV condition, TTX treatment increased the intensity of the GluA2 signal within the RE compartment, and this increase was completely blocked by KD of m3A ( Figures 6B and 6C ). This demonstrates that the deprivationinduced increase in m3A is necessary for enhanced trafficking of GluA2-containing AMPAR to RE. Interestingly, KD of m3A did not significantly affect basal levels of internal GluA2 ( Figure 6C , n = 12 neurons/condition, p = 0.40, compare EV to shm3A), suggesting that the ability of m3A KD to prevent the TTX-induced enhancement of surface GluA2 does not result from a gross defect in basal trafficking of GluA2 to RE. To determine whether upregulation of m3A was sufficient to drive GluA2 to RE, we OE FLAG tagged m3A and quantified the GluA2 signal within RE as earlier. OE of m3A significantly increased the intensity of the GluA2 signal within RE ( Figure 6D , EV, n = 46; m3A, n = 43, p = 0.014). In contrast, m3A OE did not affect the intensity of the GluA2 signal within other endosomal compartments ( Figures S6B and S6C) . Next, we asked whether m3A must interact with the AP-3 complex to traffic GluA2 to RE. The m3A subunit interacts with the AP-3A complex through its N-terminal domain and interacts with TARPs (and thus AMPAR) through its C-terminal domain (Aguilar et al., 1997; Mardones et al., 2013; Matsuda et al., 2013) . Because TTX selectively increases m3A without increasing expression of the other AP-3 subunits, and OE of m3A alone is sufficient to recruit AMPAR to RE ( Figure 6D ), we reasoned that m3A might be acting independently of the full AP-3 complex during synaptic scaling. To test this idea further, we OE a truncated form of m3A that lacks the N-terminal domain but can still recognize and bind cargo (Mardones et al., 2013) . This truncated m3A was still able to traffic to RE ( Figure S5 ), and like full-length m3A, was able to recruit GluA2 to RE ( Figure 6D , n = 22, p = 0.03).
If the recruitment of GluA2 to RE were sufficient to drive an increase in synaptic strength during synaptic scaling, then OE m3A should increase mEPSC amplitude. To test this, neurons were transfected with EV (n = 8), FLAG-tagged m3A (n = 8), or untagged m3A (n = 10) constructs; neither m3A construct was sufficient to scale up mEPSC amplitude ( Figure 6E ). Thus, increased m3A expression is necessary ( Figures 4D and 4E ) but not sufficient for the regulated recruitment of AMPAR to the synaptic membrane during synaptic scaling, suggesting that an additional trafficking step is required to bring internal AMPAR to the synaptic membrane. GRIP1 accumulates at sites of exocytosis, as well as at synapses, and is essential to recruit AMPAR to synapses during synaptic scaling up (Gainey et al., 2015; Tan et al., 2015) . To determine whether the m3A-dependent trafficking of GluA2 into the recycling pathway enhances the ability of GRIP1 to recruit GluA2 to the membrane, we compared surface levels of endogenous GluA2 after OE of m3A alone, GRIP1 alone, or m3A + GRIP1 ( Figure 6F ). While neither alone was sufficient to significantly increase surface GluA2, the two together produced a robust recruitment of GluA2 to the membrane ( Figure 6G , n = 25-33 neurons/condition, ANOVA followed by post hoc Tukey test, p = 0.024). Taken together, our data suggest a novel role for m3A in which selective activity-dependent upregulation of the m3A (cargo recognition) subunit reroutes AMPARs into the recycling pathway, where they can then be recruited to the membrane during a second trafficking step ( Figure S1 ).
DISCUSSION
To generate insight into the transcription-dependent processes that induce synaptic scaling up, we devised a cell-type-specific screen to identify a set of candidate scaling factors with altered expression during scaling. This screen identified m3A, the cargo-recognition subunit of the APC family member AP-3, as important for sorting and trafficking of membranebound cargo between endosomal compartments. Because of the known association of m3A with AMPAR, we set out to determine whether m3A has a role in the regulated changes in AMPAR trafficking that drive synaptic scaling. We found that activity blockade reroutes both m3A and GluA2 into RE, without affecting the d3 subunit, which is obligatory for complex formation. KD of m3A prevented synaptic scaling and the redistribution of GluA2 into RE, while OE of either full-length m3A or a truncated form that cannot interact with the AP-3A complex was sufficient to drive GluA2 to REs. Finally, OE of m3A acted synergistically with GRIP1 to recruit GluA2 to the cell surface. Taken together, these data support a model in which excess m3A acts independently of the AP-3A complex to reroute AMPAR to RE, from which they are recruited to the synapse to enhance synaptic strength during scaling up ( Figure S1 ).
We used an unbiased cell-type-specific profiling approach (Sugino et al., 2006 ) that allowed us to probe for persistent transcriptional changes in a population of neurons (L4 star pyramidal neurons from V1) known to undergo synaptic scaling in response to visual deprivation during early postnatal development (Desai et al., 2002) . None of the small number of candidates identified (Table 1) had previously been associated with synaptic scaling. There is no overlap between this candidate set and transcripts previously found to be regulated by visual deprivation in V1 of rodents or primates (Nedivi et al., 1996; Lachance and Chaudhuri, 2004; Majdan and Shatz, 2006; Tropea et al., 2006) . This is likely due to large methodological differences in approach; most importantly, these previous studies probed whole V1 extracts, while here we probe changes in a specific cell type as these neurons are undergoing synaptic scaling. Because of the complexity of neocortical circuits and cell types and the diversity of plasticity mechanisms present (Feldman, 2009; Nelson and Turrigiano, 2008) , this cell-type-specific approach is likely critical for identifying candidates that are tied to particular forms of neocortical plasticity, rather than general circuitwide responses to deprivation or other activity paradigms.
Interestingly, none of the signaling and trafficking proteins that have previously been linked to synaptic scaling through a candidate approach came up in our screen (Table S1) . As an example, the essential scaling factor GRIP1 is not transcriptionally regulated, consistent with the observation that although GRIP1 increases at synapses during scaling, this is not accompanied by an increase in total GRIP1 protein (Gainey et al., 2015) . This underscores the point that synaptic scaling involves the activity-dependent regulation of several AMPAR trafficking steps, only some of which are regulated at the level of transcription. We chose to focus on m3A because AP-3 plays a role in trafficking of receptors into dendrites and/or to the neuronal surface ( Matsuda et al., 2008; Bendor et al., 2010) and, more recently, AP-3A has been shown to interact with AMPAR through an indirect association involving m3A binding to the TARP stargazin (STG), an association that is important for the induction of long-term depression (LTD) (Matsuda et al., 2013) . None of the tetrameric APC family member subunits were previously known to exhibit activity-dependent transcriptional regulation, whereas here we find that both m3A and m4 (but not any other subunits of either APC) were upregulated by day 2 of visual deprivation. AP-3A is primarily known for a role in sorting cargo from the Golgi or EE to lysosomes or lysosome-related organelles (LROs) (Dell'Angelica, 2009; Dell'Angelica et al., 1997; Peden et al., 2004) , and during LTD, the association of m3A with stargazin enhances the trafficking of AMPAR to lysosomes (Matsuda et al., 2013) . Thus, it was a surprise to find that during synaptic scaling, the upregulation of m3A leads to enhanced accumulation of m3A and AMPAR within the RE compartment and a reduction in the association of m3A with lysosomes. These data show that the localization of m3A is dynamic and can be regulated by activity to redirect cargo (in particular, AMPAR) into the recycling endocytic pathway.
The RE compartment has been shown to be critical for supplying AMPAR during LTP (Hanley, 2010; Park et al., 2004) , but whether they also supply AMPAR for synaptic scaling has been less clear (Gainey et al., 2015; Tan et al., 2015) . Interestingly, although an increase in m3A is necessary for scaling, and is necessary and sufficient to drive AMPAR to RE, it is not sufficient to increase mEPSC amplitude. This suggests that once AMPAR are rerouted into the recycling pathway by m3A, they must still be recruited to the synaptic membrane in a second activity-dependent trafficking step. The GluA2-interacting protein GRIP1 plays a critical role in recruiting AMPAR from internal endosomal compartments to the synaptic membrane during synaptic scaling (Gainey et al., 2015; Tan et al., 2015) . Here we show that when m3A and GRIP1 are OE together, they can act synergistically to enhance surface AMPAR accumulation, providing direct experimental support for a two-step trafficking model in which m3A recruits AMPAR into the recycling pathway, where they can then be recruited to and stabilized by GRIP1 at the synaptic membrane ( Figure S1 ).
Systemic loss of functional AP-3 causes endosomal trafficking defects, Hermansky-Pudlak syndrome, and neurological symptoms (Kantheti et al., 1998; Lane and Deol, 1974; Peden et al., 2002; Seong et al., 2005; Sirkis et al., 2013; Swank et al., 2000; Yang et al., 2000) . These have mainly been ascribed to defects in lysosomal trafficking and/or biogenesis of LROs. Our data suggest that the m3A subunit traffics AMPAR away from lysosomes and into the recycling pathway by acting independently of the full AP-3 complex. Three main pieces of evidence support this idea. First, while m3A is upregulated during synaptic scaling, the d3 subunit is not. Because the d3 subunit is obligatory for formation of both the AP-3A and the AP-3B complexes (Kantheti et al., 1998; Peden et al., 2002) , this suggests that either m3A is limiting for complex formation or that activity-induced m3A is not acting as part of the complex. The latter interpretation is favored by the observation that the intensity of the m3A signal increases even in endosomal compartments with no detectible d3. Second, we find that OE of m3A alone is sufficient to recruit AMPAR to RE and to enhance the ability of GRIP1 to recruit AMPAR to the dendritic membrane. Finally, OE of a truncated m3A that cannot interact with the AP-3 complex is also able to recruit AMPAR to RE. These data show that selectively increasing m3A is able redirect AMPAR into the recycling pathway, possibly by protecting AMPAR from association with the full AP-3 complex. Once in the recycling pathway, they can be recruited to the synapse during a subsequent trafficking step, likely involving GRIP1 ( Figure S1 ).
Taken together, our data identify m3A as an essential transcription-dependent switch point that can redirect AMPAR to RE during synaptic scaling. These data show that both scaling up and LTP share a common reliance on AMPAR trafficking to the RE compartment (Ehlers, 2000; Park et al., 2004) . Furthermore, AP-3 is important for trafficking AMPAR to lysosomes during LTD (Matsuda et al., 2013) . This raises the possibility that competition between AP-3 and m3A for the binding and sorting of AMPAR is a key mechanism underlying several distinct forms of synaptic plasticity.
EXPERIMENTAL PROCEDURES
All experiments were approved by the Brandeis Animal Care and Use Committee and were in accordance with NIH guidelines. Experiments were performed on animals of both sexes. Detailed methods are provided in Supplemental Experimental Procedures. Briefly, cultures were prepared and transfected 72 hr before recording or staining as described (Pratt et al., 2003) . For culture physiology, mEPSC recordings were obtained from visually identified pyramidal neurons and analyzed as described previously Wierenga et al., 2005) . At P12 or P13, HsCt5 mice were subjected to monocular deprivation by intraocular injection of TTX (1 mM) as described (Desai et al., 2002; Maffei and Turrigiano, 2008) ; injections were performed twice (at P12 or P13 and then again at P13 or P14) to maintain the block for 48 hr. For slice electrophysiology, coronal brain slices from HsCt5 mice (300 mm) containing monocular primary visual cortex (V1m) were prepared from control and deprived hemispheres (P14-P15) and recordings were obtained from labeled neurons as described (Maffei et al., 2006; Loebrich et al., 2013) .
Microarray Screen
Isolation of labeled neurons, RNA preparation, and microarray screening from L4 V1 from the HsCt5 line was performed as described previously (Sugino et al., 2006; Hempel et al., 2007) , using 30 to 50 labeled cells from either the deprived or the control hemisphere for each of three replicates. To stabilize the probe effects (i.e., probe-specific sources of variance), we used an approach similar to the frozen robust multiarray analysis (fRMA) method developed by McCall et al. (2010) ; details are given in Supplemental Experimental Procedures. Data were filtered by fold change > 1.5, and the top 30 probes (ranked by p value) annotated to RefSeq genes were included in Table 1 .
Antibody Generation and Characterization
A rabbit anti-m3 polyclonal antibody was raised against the peptide DMYGEK YKPFKGVKY (LifeTein, residues 393-407) by Cocalico Biologicals. Bleeds were examined and specificity was confirmed by western blot analysis against cortical extracts, and 293 lysates (ATCC) transfected with Ap3m1, Ap3m2, or Ap4m1-mCherry expression vectors. Immunohistochemical staining was abolished by preabsorption with the peptide used to generate the antibody ( Figure S3C ) and was decreased when mu3A was knocked down by RNAi (Figures 4A-4C ).
Statistical Analysis
Data are presented as mean ± SEM for the number of neurons indicated. Each experiment was repeated on at least three separate animals or dissociations, and the n values represent the number of neurons. To determine statistical significance, unpaired two-tailed Student's t tests-or, for multiple comparisons, single-factor ANOVAs followed by a Tukey test or a Kruskal-Wallis test followed by a Dunn-Bonferroni post hoc test-were run as appropriate. p values % 0.05 were considered significant.
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